Introduction {#s1}
============

*Listeria monocytogenes* is a great concern both for industrial and public health stakeholders. These bacteria cause listeriosis, a foodborne disease acquired through the consumption of contaminated ready-to-eat products, including milk or meat products. Pork meat has been associated with large-scale outbreaks in the past ([@R15]) and is considered a risk factor, particularly for sensitive populations such as pregnant women, children and the elderly. In the last few years, the increase in human cases (not associated with intensified surveillance), mainly for the elderly, has increased the concern surrounding management of *L monocytogenes* in food in Canada and Europe ([@R13]). One critical question to answer is whether the virulence of *L monocytogenes* has increased. The determinants of virulence have been studied, and there is a large amount of data that allow for discrimination of strains from lineages III or IV from lineages I and II ([@R3]). Lineages I and II are considered to be the most worrisome because of their potential to cause outbreaks or sporadic listeriosis. Among such strains, discrimination based on pathogenic properties still represents a challenge. A few years ago, the very promising concept of virulence determination through *inlA* gene sequencing was introduced ([@R5], [@R6]). Published studies revealed the presence of a premature stop codon for internalin A translation. Because this stop codon inactivated this determinant of the first step of pathogenicity in the digestive tract, a key determinant for virulence differentiation of strains appeared to have been discovered. In Quebec, human listeriosis surveillance works hand-in-hand with food surveillance. Few strains isolated from clinical cases in farms (animal primary productions) are available, so we took the opportunity that arose to test virulent strains isolated from animals or humans with clinical signs of listeriosis. After we performed the serovar determination and comparison according to strain origin, we wanted to confirm if the *inlA* sequences were complete in these strains and to test their behaviour in a *Caenorhabditis elegans* infection model, a very attractive but controversial model of pathogenicity testing for *L monocytogenes* ([@R12], [@R11]) (see discussion). No relationship between InlA integrity and behaviour of *L monocytogenes* strain in *C elegans* has actually been described. Some strains isolated during a previous study involving pig primary production ([@R1]) were added to the study's strain collection because only some of them showed stop codon in their *inlA* sequences and because these strains were (based on pulsotype comparison) frequently or not associated with clinical human cases. These additional strains were expected to show opposite virulence potentials. The aim of this study was to analyse *inl*A sequences from strains isolated from clinical forms of human or animal listerioses in Quebec and to compare the behaviour of some selected strains in a *C elegans* virulence model.

Materials and methods {#s2}
=====================

Strain collections {#s2a}
------------------

Strains were collected from *L monocytogenes* surveillance in 2013/2014: 20 strains were obtained from animal disease surveillance (laboratory of the Ministry of Agriculture, Fisheries and Food, Quebec (MAPAQ)), among which 13 were included in this study because they satisfied the required 'clinical' criteria (ie, isolated from organs after animal necropsy, excluding isolation from milk and silage) and 16 strains isolated from clinical cases in humans were provided by the Provincial Public Health Laboratory (public health surveillance). The collection was completed with four strains of pig origin isolated in a previous project ([@R1]). These strains showed a single nucleotide polymorphism (SNP) premature stop codon in the inlA sequence (Pulso1 and Pulso9 strains) or an integrated inlA sequence (Pulso4 and Pulso6 strains). Strains Pulso6 and Pulso9 showed 100% similarity between pulsed-field gel electrophoresis (PFGE) banding patterns with strains recovered from clinical human cases; strains Pulso1 and Pulso4 have not previously been identified in clinical human surveillance. These added strains were expected to show opposite virulence potentials.

Serotyping {#s2b}
----------

*L monocytogenes* strains were serotyped based on a combination of multiplex PCR-based geno-serogrouping, completed by detection of *fla*A ([@R2]) and agglutination against discriminatory O serum (OI, OVII, OVIII; Oxoid Thermo Fisher Scientific, Nepean, ON, Canada) ([@R16]).

*InlA* sequencing {#s2c}
-----------------

The *inlA* gene sequences were determined after overlapping amplification ([@R3]) using the Sanger method at the Centre d'Innovation Génome Québec (Applied Biosystems 3730xl DNA analyzer). *InlA* gene sequencing was extensively analysed, and the occurrence and position of SNP before in silico translation of the sequences were compared. Sequences were aligned and screened for mutations causing a premature stop codon or amino acid deletion using ClustalX 2.1 software, with *inlA L monocytogenes* EGD-e (NCBI: NC_003210.1) as reference.

*C elegans* virulence model {#s2d}
---------------------------

Bacterial strains ([Fig 1](#F1){ref-type="fig"}) were cultured 24 hours at 37°C in BHI (Brain Heart Infusion), acid shocked (0.1 N HCl pH 4.5, one hour) then washed and suspended in phosphate-buffered saline (PBS) (concentration, see [Fig 1](#F1){ref-type="fig"}) before being used in trials. Strain N2 worms, maintained for five days on nematode-growing medium plates and inoculated with *Escherichia coli* OP50 feeding strain at 25°C, were harvested (non-synchronised culture), washed three times in PBS, then inoculated in 96-well plates in PBS and maintained for five more days at 30°C with daily addition of fresh bacteria.

Observation of worm viability (based on worm locomotion and/or pharyngeal pumping and assessed under an inverted phase contrast microscope according to [@R12] ([@R12]) allowed determination of a living worm count of 15 mature worms and 30 L1/L2 larvae in each of the tested conditions. The distribution of number of living worms counts (n=8) were compared with control conditions (Mann-Whitney U test; SPSS Statistics V.17, Licenced U de Montreal, α=0.05)

Results {#s3}
=======

All 16 of the strains of human origin were considered clinical because they were isolated from hospitalised patients. From the 20 strains provided by MAPAQ, only 13 strains strictly associated with clinical listeriosis in animals were included. It should be noted that we excluded strains isolated from milk tanks and silage, all belonging to the 1/2a serovar. Although serotyping revealed that the greater proportion of clinical strains (regardless of origin) belonged to the serovar 1/2a (18/29, 62%), there were still some strains (nine out of 29 with similar proportions from humans and animals, that is, 5/16 and 4/13, respectively) that belonged to the IVB serogroup (a serogroup that contains 4b and 4a/ab serovars). Focusing on this IVB group, a clear distinction appeared where only 4b serovar strains were found in human surveillance, whereas strains shown in ruminant clinical cases all belonged to 4a/4ab serovars (table presented in [Fig 2](#F2){ref-type="fig"}). No SNP occurred on the sequence coding for the InlA LPXTG domain. Moreover, *inl*A sequencing showed that a majority of strains had a complete sequence (table presented in [Fig 2](#F2){ref-type="fig"}). But it should be noted that two out of the 16 strains isolated from clinical listeriosis cases had a premature stop codon; the mutations were expected to induce truncations of InlA at 700 and 762 amino acid (aa) positions, respectively. One of these---which showed the longest InlA size but lost LPXTG domain---was used in the *C elegans* virulence model, as well as another strain presenting a complete sequence (tables presented in [Figs 1,2](#F1 F2){ref-type="fig"}). Four more strains (different PFGE type) from porcine origin were added; some had been recurrently detected in production (and food) but had never been associated with human cases (table presented in [Fig 1](#F1){ref-type="fig"}; Pulso1 and Pulso4 strains). The two others were kept because of their 100% homology with strains involved in clinical human cases (sporadically for strain Pulso9 or recurrently for strain Pulso6; table presented in [Fig 1](#F1){ref-type="fig"}). After five days, unfed *C elegans* worms were almost all dead. Using *E coli* OP 50 as a control, viability was maintained at 74% after five days, both in larvae and in mature worm forms. By comparison, *L monocytogenes* lowered the viability of the worms and significantly so for the larvae forms (Mann-Whitney U test, P\<0.05). No differences in virulence behaviour were revealed using this model to compare the *L monocytogenes* strains ([Fig 3](#F3){ref-type="fig"} and [Fig 4](#F4){ref-type="fig"}). The strain that was expected to be the least virulent (Pulso1) showed the largest decrease in value for worm viability for both forms (50% and 55%, respectively, for larvae and mature worms) (table presented in [Fig 1](#F1){ref-type="fig"}).

![*Listeria monocytogenes* virulence on *Caenorhabditis elegans* model isolated in human (h) or pig (s). h s: strains from animal origin related to human cases (identical pulsed-field gel electrophoresis profile). Comp: complete InlA; PSC 700: truncated InlA due to the presence of a 700 aa position premature stop codon. Comp.\#: complete but with substitution of first amino acids. aa, amino acid.](vetreco-2016-000199f01){#F1}

![: Characterisation of *Listeria monocytogenes* strains of clinical origin. PSC, premature stop codon (aa position). Dele aa: deletion of first amino acids in the protein. na: not applicable; nr: not recorded. **Bold**: retained for *C elegans* testing. ](vetreco-2016-000199f02){#F2}

![Evolution of mean live number *C*aenorhabditis* elegans* larvae out of 30 (n=8). Mean (n=8) number of live *C elegans* larvae out of 30 after one to five days in contact with bacterial strain (see [Fig 1](#F1){ref-type="fig"}). Bars: SD.](vetreco-2016-000199f03){#F3}

![Evolution of mean number of live mature *C*aenorhabditis* elegans* out of 15 (n=8). Mean (n=8) number of live *C elegans* mature out of 15 after one to five days in contact with bacterial strain (see [Fig 1](#F1){ref-type="fig"}). Bars: SD.](vetreco-2016-000199f04){#F4}

Discussion {#s4}
==========

*L monocytogenes* virulence determination is a current research concern, and many authors have contributed to the advancement of this endeavour. A quite recent proposition (relevant when considering the capital role of Inl*A* in pathogenicity) is that the truncation of Inl*A*, induced by the presence of a premature stop codon in *inlA*, is associated with lower virulence properties ([@R4]). Moreover, a great proportion of truncated forms were shown in strains isolated from food or food-related environments but not in *L monocytogenes* strains involved in clinical human cases ([@R5]). Discussion of the relevance of this virulence determinant arose when it was demonstrated that some truncated forms can express virulence in animal models ([@R6], [@R7]). Our analyses confirm that truncated forms can be found in clinical human cases in Quebec. The truncation positions, induced by SNP stop codon (700 and 762 aa) were previously reported ([@R14]). For the 700 aa truncation position, the entire anchorage region (between 700 and 800 aa), including the determinant proline in the LPXTG motif, was not translated. So, at least for the strain harbouring the 700 aa truncated InlA, pathogenicity was expected to be extremely low. The clinical origin of such strains led us to question the dose of ingested inoculum. In studies that demonstrated, in experimental conditions, a maintenance of virulence for strains harbouring truncated Inl*A*, high doses of inoculum were used ([@R6], [@R7]). High-dose ingestion of *L monocytogenes* could be observed in outbreaks, giving an opportunity for a strain harbouring Inl*A* truncated form to cause disease. We suggest that *inlA* analysis alone is not sufficient to characterise the virulence potential of *L monocytogenes* strains.

Looking for a complementary test that avoids labour intensive and ethically questioned experimentations on mammal models, we considered the *C elegans* model for comparing the virulence of our characterised strains. The *C elegans* model was first proposed in 2006 and confirmed in 2007 ([@R12], [@R8]) when studies showed that the worm is as sensitive to pathogenic *L monocytogenes* as humans. But Guha and others questioned the model in 2013 ([@R9]) after failing to obtain loss of viability of worms inoculated by *L monocytogenes*. That same year, [@R10] ([@R10]) confirmed that primed strains (acid shocked) increase the lethality to the worms and ultimately confirmed the worm model as able to compare virulence for food-derived strains ([@R11]). Our results, when incubating worms at 30°C with acid-shocked *L monocytogenes* (to promote prfA-driven virulence factors in the pathogen), confirmed a decrease of viability of worms in contact with *L monocytogenes* (in a lesser proportion than *Salmonella* Typhimurium). Contrary to the work of [@R11] ([@R11]), the worms did not show any morphological changes when they were submitted to our *L monocytogenes* strain inoculations. The loss of viability was solely based on immobility and loss of pharyngeal pumping activity, in accordance with [@R10] ([@R10]). In our conditions, neither on both the mature form nor on the young larvae, *L monocytogenes* showed differences in virulence regardless of origin (environmental or clinical) and in their *inlA* integrity.

Conclusion {#s5}
==========

Using complete serotyping, differences in IVB geno-serogroup between clinical strains from bovine and human origins were shown, with serovar 4b found only in human clinical case strains. The virulence analysis tools used in this study (*inl*A sequencing and *C elegans* model) on both confirmed virulent and presumed less virulent strains could not univocally established the public health risk associated with *L monocytogenes* strains. No pig clinical case strains were provided by the MAPAQ laboratory, but serovar 4b strains were previously found in the collection of strains from healthy pigs in primary production ([@R1]). As calls for farm to fork strain traceability continue to be made, accurate surveillance is needed to enlarge the collection of strains in animal surveillance, particularly from pig production. It should be mentioned that we did receive all the collected *L monocytogenes* strains isolated in the MAPAQ laboratory, and we observed that they mainly originated from bovine clinical surveillance (where *L monocytogenes* present economical relevance).

*C elegans* were kindly provided by Caenorhabditis Genetics Center, University of Minnesota, Minneapolis, Minnesota, USA.
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